Cyberattack Alert - Severe WARNINGS & CAUTIONS to All Members
NASDAQ 6,840.08 117.68 (+0.39%) DJIA 24,329.16 117.68 (+0.48%) S&P 500 2,651.50 14.52 (+0.55%) 08/12/2017 17:00

Stem Cell News


Magenta Therapeutics' Lead Targeted Antibody Drug Conjugate Shows Promising Preclinical Results for Non-Genotoxic Conditioning for Bone Marrow Transplant

09/12/2017 15:00

-- A single dose of CD117 ADC shows selective depletion of human hematopoietic stem cells a...

73% of Respondents Say One or More Diseases Run in Their Family; Just 6% Don't Want Genetic Testing -- Wamberg Genomic Survey

08/12/2017 00:02

LA JOLLA, Calif. , Dec. 7, 2017 /PRNewswire/ -- Seventy-three percent of respondents...

New Data Published in Journal Cell Show Robust Mobilization of Highly Engraftable Stem Cells in Mouse Models with Combination of GRO? and Plerixafor

07/12/2017 18:00

-- Publication from scientific collaboration lays foundation for Magenta Therapeutics data ...

Adaptimmune Data to be Presented at American Society of Hematology (ASH) Annual Meeting Confirm NY-ESO SPEAR T-cell Efficacy in Multiple Myeloma Pilot Study

05/12/2017 23:00

PHILADELPHIA, Pa. and OXFORD, UK, Dec. 05, 2017 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutic...

Scientists Create Successful Mass Production System for Bioengineered Livers

05/12/2017 18:00

CINCINNATI , Dec. 5, 2017 /PRNewswire-USNewswire/ -- Researchers report creating a b...

Poseida Therapeutics Presents Preclinical Solid Tumor Data for P-PSMA-101 at the American Association for Cancer Research Prostate Cancer Meeting

05/12/2017 14:00

SAN DIEGO, Dec. 05, 2017 (GLOBE NEWSWIRE) -- Poseida Therapeutics Inc. (“Poseida...

NextMed Center of Carlsbad Announces Medical Campus Grand Opening

05/12/2017 12:00

SAN DIEGO , Dec. 5, 2017 /PRNewswire/ -- NextMed Center of Carlsbad , San Diego's ...

Nerve Repair and Regeneration Market by Application & Product - Global Forecast to 2022 - Research and Markets

30/11/2017 12:12

The "Nerve Repair and Regeneration Market by Application (Neurorrhaphy, Nerve Grafting, Ste...

Page of 89

Terms and Conditions | Privacy Statement
Financial.org is an educational platform. We DO NOT deal with securities and receive any financial benefits from Financial Products & Service Providers.